Drug Discovery World

AUGUST 13, 2024

Professor Andy Whiting , CEO of Nevrargenics, asks whether animal models should be used as the default regulatory requirement and explores the times to use them. Animal models (AMs) have generally been seen as useful for drug development and biomedical research for many years. Are AMs always necessary and unavoidable?

Drug Development 162

Drug Development Animal Testing Regulations Drugs 162

Drug Discovery World

JANUARY 26, 2024

Be sure to attend the Ignite Theater at SLAS2024 in Boston on 5 and 6 February 2024. Dr Bentwich will present on ‘ How artificial intelligence and patient-on-a-chip are improving drug development ’ on Tuesday 6 February at 3pm.

Clinical Trials 130

Clinical Trials Trials Animal Testing Pharma Companies 130

Drug Discovery World

JANUARY 21, 2024

Bushell will discuss the history and technological underpinnings of induced proximity, the lessons learned from the PROTAC (proteolysis-targeting chimeric) example, and how technology can create enhancement-targeting chimeric, or ENTAC, drugs and fully realise the potential of targeted protein enhancement. Is pharma’s commercial model dying?

Vaccine 130

Vaccine Computational Chemistry Animal Testing Engineering 130

Vial

MAY 20, 2024

Clinical CROs in Clinical Research Randomized clinical trials are the gold-standard of evidence-based medicine, representing the culmination of the long, arduous drug development pipeline. The two broadest categories of drug development can be separated into the preclinical and clinical research stages. over this period.

Clinical Research 52

Clinical Research Research Clinical Trials Laboratories 52

Drug Target Review

SEPTEMBER 10, 2024

The current landscape of protein drug development is characterised by accelerated timelines where new drugs are approved in months rather than years. Hence, in many cases an earlier IND may be prevented by the timely provision of representative Drug Substance (DS) to execute such toxicology studies.

Clinical Supply 64

Clinical Supply Drug Development Production Animal Testing 64

Drug Discovery World

JULY 3, 2024

Protocol AI, which was created by Risklick, a spin-off from the University of Bern, uses artificial intelligence to enable faster drafting of clinical trial protocols with the aim of accelerating drug development, reducing costs and improving safety standards. Meanwhile, Lugano-based Anthropos raised $2.7m

Drugs 130

Drugs Clinical Trials Science Therapies 130

Codon

JUNE 2, 2024

” It’s an uncharitable take, but when drugs fail as often as they do despite animal testing, it’s not hard to see the JAX mice as a metaphor for a biomedical enterprise cloistered away from the real world. ” Asimov Press (2024). Cite this essay: Alex Telford. “The Mouse as a Microscope.”

Laboratories 117

Laboratories Research Disease Science 117